We need to know the 'why' before worrying about the 'how'
The latest episode of 'The Dispatched Podcast' discusses Labor's call for the Coalition to match its commitment to a national takeover of newborn screening and why the health technology assessment rev...
8 Mai 202227min
Newborn screening - the how, the what and the why?
In this week's episode, the 'Dispatched Podcast' discusses Labor's commitment to a national takeover of newborn screening. Why is there a need for change? What does the change mean for Australian fami...
6 Apr 202225min
Budget 2022-23 and the lowering of expectations
What is in Budget 2022-23 and what is not. The lack of action on medicines affordability, funding for pre-symptomatic treatments but not screening for the disease and how the PBS forecast is money ou...
28 Mar 202229min
Political condescension, the biggest reform in 30 years and next week's Budget
The political and policy condescension of patients needs to stop. The health technology assessment review has been called one of the biggest health reforms in the past 30 years. What is the competitio...
21 Mar 202233min
'It should be about affordability for patients, not the government'
The co-founder and chair of Better Access Australia, Felicity McNeill PSM, discusses the organisation's call for a delay in the National Medicines Policy review following the recent release of the rev...
5 Feb 202218min
Nicole Cooper - 'I am a patient, not a consumer'
BioPharmaDispatch is finishing 2021 with a podcast with Nicole Cooper of Convalis Consulting.Ms Cooper is approaching the fifth anniversary of her diagnosis with an advanced form of cancer. She talks ...
19 Des 202131min
Novartis' Richard Tew - 'Collaboration and intent but the system needs a design change'
The general manager and country president of Novartis Pharmaceuticals Australia and NZ, Richard Tew, says there are actions the government can take now to enhance the eco-system for biopharmaceutical ...
18 Des 202128min
PAIG - J&J's Fiona Sheppard and Pfizer's Lee Davelaar
The co-chairs of the Pharma Australia Inclusion Group, J&J's Fiona Sheppard and Pfizer's Lee Davelaar, discuss their personal journeys on diversity and inclusion, the group's activities in 2021, inclu...
15 Des 202126min
